Community Bank’s Revolution Medicines RVMD Stock Holding History

Community Bank’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-5	Closed	–	–	655
2022 Q3	$0	Buy	+5	New	+$110	﹤0.01%	687

Other funds holding RVMD

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Community Bank's RVMD Position: Q4 2022 in Review

Community Bank sold out of Revolution Medicines (RVMD) in Q4 2022, closing a stake of 5 shares.

Community Bank first reported a position in RVMD in Q3 2022 and held it in 1 quarter. The position peaked at $0 in Q3 2022. 135 funds tracked by Wall St. Rank hold RVMD as of Q4 2022.

Community Bank reported no remaining Revolution Medicines position as of Q4 2022 after selling out during the quarter.
Community Bank sold 5 Revolution Medicines shares in Q4 2022.
Community Bank first reported a position in Revolution Medicines in Q3 2022 and held it in 1 quarter.
Community Bank's Revolution Medicines position peaked at $0 in Q3 2022.
135 funds tracked by Wall St. Rank held Revolution Medicines as of Q4 2022.

Based on Community Bank's 13F filing for Q4 2022, filed 31 Jan 2023.